Dr. Isaac H. Tawfik, MD

Dr. Tawfik practices at Saint Barnabas Rcg Dialysis Center-Livingston - HOPD in Livingston, New Jersey.

Dr. Tawfik's NPI, 1073612990, was assigned on September 21, 2006. Dr. Tawfik graduated from Temple University School of Medicine in 2003. Dr. Tawfik holds New Jersey license 25MA08003200.

Dr. Tawfik's primary practice is Saint Barnabas Rcg Dialysis Center-Livingston - HOPD, at 200 S Orange Ave, Livingston, NJ 07039.

Dr. Tawfik's primary practice is Saint Barnabas Rcg Dialysis Center-Livingston - HOPD in Livingston, New Jersey. Dr. Tawfik is also affiliated with Robert Wood Johnson University Hospital. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Tawfik to 4 more hospitals, 2 group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tawfik practices, 9 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Tawfik's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Tawfik is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Tawfik is licensed in New Jersey.

CMS data shows 6,428 Medicare services from Dr. Tawfik across 38 procedure codes in 2024, for 1,902 Medicare patients. Medicare paid $682,113 for them.

CMS counts 1,902 Medicare patients who saw Dr. Tawfik in 2024. The largest group is 65 to 74, with 766 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tawfik's median patient age at 66, with 58% women.

In 2024, Dr. Tawfik wrote 5,643 Medicare Part D claims for 754 patients. 83% of them were for generic drugs. CMS names the drug for 5,400 of them, across 53 drugs with 11 or more claims each, at $990,924 in total drug cost. In 2023, CMS named 3,745 claims across 50 drugs.

Dr. Tawfik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 222 procedures of varicose vein removal by Dr. Tawfik, more than 91% of the clinicians it reports for that procedure.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 890 general payments to Dr. Tawfik from 73 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Novartis Pharmaceuticals Corporation paid the most, $10,292.

Dr. Tawfik graduated from Temple University School of Medicine in 2003.